Related Experiment Video
Updated: Nov 28, 2025

Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
Published on: July 28, 2022
Enteral Feeding Intolerance: Updates in Definitions and Pathophysiology
Annika Reintam Blaser1,2, Adam M Deane3, Jean-Charles Preiser4
1Department of Intensive Care Medicine, Lucerne Cantonal Hospital, Lucerne, Switzerland.
Enteral feeding intolerance (EFI) lacks a clear definition in critically ill patients, hindering research and consistent clinical practice. This review proposes a framework for a standardized EFI definition to improve patient outcomes.
Area of Science:
- Critical Care Medicine
- Gastroenterology
- Clinical Nutrition
Background:
- Enteral feeding intolerance (EFI) is prevalent in critically ill patients.
- Existing definitions of EFI are inconsistent, complicating research and clinical application.
- EFI is often linked to delayed gastric emptying but may involve diverse pathophysiological mechanisms.
Purpose of the Study:
- To review current definitions and pathophysiological mechanisms of EFI.
- To explore the clinical relevance and impact of EFI on patient outcomes.
- To propose a conceptual framework for a standardized EFI definition.
Main Methods:
- Literature review of existing definitions of EFI.
- Analysis of pathophysiological mechanisms contributing to EFI.
- Synthesis of evidence on clinical relevance and patient outcomes associated with EFI.
Main Results:
- Significant heterogeneity exists in current EFI definitions.
- Multiple underlying mechanisms contribute to EFI, leading to varied clinical presentations.
- A pragmatic clinical definition and a research-oriented definition are both necessary.
Conclusions:
- A consensus on a standardized definition for enteral feeding intolerance is crucial.
- A proposed conceptual framework can guide future research and clinical consensus.
- Standardizing EFI definitions will enhance understanding and improve interventions for critically ill patients.
Related Concept Videos
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Enteral Nutrition I: Orogastric and Nasogastric Feeding
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.

